Germline pathologic mutations and cancer family history in prostate cancer patients.

被引：0
|
作者：
Moses, Marcus Marie
Ledet, Elisa
Ernst, Emma M.
Cotogno, Patrick
Schiff, Joshua
Lewis, Brian E.
Sartor, A. Oliver
机构：
[1] Tulane Univ, New Orleans, LA USA
[2] Tulane Univ Canc Ctr, New Orleans, LA USA
[3] Tufts Sch Med, Medford, MA USA
[4] Tulane Canc Ctr, Off Clin Res, New Orleans, LA USA
[5] Tulane Univ Sch Med, New Orleans, LA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期
关键词：
D O I：
10.1200/JCO.2018.36.6_suppl.378
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
378
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Family History of Breast or Prostate Cancer and Prostate Cancer Risk
    Barber, Lauren
    Gerke, Travis
    Markt, Sarah C.
    Peisch, Samuel F.
    Wilson, Kathryn M.
    Ahearn, Thomas
    Giovannucci, Edward
    Parmigiani, Giovanni
    Mucci, Lorelei A.
    CLINICAL CANCER RESEARCH, 2018, 24 (23) : 5910 - 5917
  • [42] Assessing somatic and germline variants in cancer patients.
    Ricker, Charite
    Amundson, Erika
    Algaze, Sandra
    Ciccone, Marcia
    Dong, Stephen
    D'souza, Anishka
    Felicetti, Kimberly
    Hernandez, Daisy
    Jayachandran, Priya
    Kang, Irene
    Narayanan, Kavitha
    Thomas, Jacob Stephen
    Tulpule, Varsha
    Umayam, Rebecca
    Xia, Bing
    In, Gino Kim
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [43] GENE MUTATIONS AMONG PROSTATE CANCER PATIENTS WITH A SMOKING HISTORY
    El-shafie, Ahmed
    Feibus, Allison H.
    Al-Toubat, Mohammed
    Lelani, Navid
    Jazayeri, SeyedBehzad
    Koul, Kashyap
    Marino, Robert A.
    Bandyk, Mark
    Costa, Joseph
    Balaji, K. C.
    JOURNAL OF UROLOGY, 2023, 209 : E220 - E221
  • [44] Diagnostic yield of germline genetic testing following tumor testing in prostate cancer patients.
    Das, Kingshuk
    Lincoln, Stephen E.
    Ngo, Nhu
    Alvarez, Daniel Esteban Pineda
    Yang, Shan
    Michalski, Scott T.
    Nielsen, Sarah M.
    Esplin, Edward D.
    Nussbaum, Robert Luke
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [45] Family history of prostate cancer in patients with localized prostate cancer: An independent predictor of treatment outcome
    Kupelian, PA
    Kupelian, VA
    Witte, JS
    Macklis, R
    Klein, EA
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) : 1478 - 1480
  • [46] Germline heterozygous BLM mutations and prostate cancer risk.
    Ledet, Elisa
    Antonarakis, Emmanuel S.
    Pritchard, Colin
    Isaacs, William B.
    Sartor, A. Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [47] Germline mutations and prostate cancer: is it time to change treatment algorithms?
    Telvizian, Talar
    Mukherji, Deborah
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (05)
  • [48] MSH6 germline mutations in early-onset colorectal cancer patients without family history of the disease
    Pinto, C.
    Veiga, I.
    Pinheiro, M.
    Mesquita, B.
    Jeronimo, C.
    Sousa, O.
    Fragoso, M.
    Santos, L.
    Moreira-Dias, L.
    Baptista, M.
    Lopes, C.
    Castedo, S.
    Teixeira, M. R.
    BRITISH JOURNAL OF CANCER, 2006, 95 (06) : 752 - 756
  • [49] Novel Germline Mutations in a Cohort of Men with Familial Prostate Cancer
    Mondschein, Romy
    Bolton, Damien
    Clouston, David
    Dowty, James
    Kavanagh, Liam
    Murphy, Declan
    Scott, Prudence
    Taylor, Renea A.
    Thorne, Heather
    CANCERS, 2022, 14 (15)
  • [50] Germline BRCA Mutations Denote a Clinicopathologic Subset of Prostate Cancer
    Gallagher, David J.
    Gaudet, Mia M.
    Pal, Prodipto
    Kirchhoff, Tomas
    Balistreri, Lisa
    Vora, Kinjal
    Bhatia, Jasmine
    Stadler, Zsofia
    Fine, Samson W.
    Reuter, Victor
    Zelefsky, Michael
    Morris, Michael J.
    Scher, Howard I.
    Klein, Robert J.
    Norton, Larry
    Eastham, James A.
    Scardino, Peter T.
    Robson, Mark E.
    Offit, Kenneth
    CLINICAL CANCER RESEARCH, 2010, 16 (07) : 2115 - 2121
12345